Preparing an Approach to Cold Chain for Cell- and Tissue-Based Therapies

Shanley,Agnes;

Publication

Article

May 15, 2017

BioPharm International

BioPharm International-05-15-2017

Volume2017 eBook

Issue 1

Pages: s35-s38

Preparing an Approach to Cold Chain for Cell- and Tissue-Based Therapies

Author(s):

Agnes Shanley

Andrea Zobel, senior director of product management, clinical trial supply, and logistics at PAREXEL International, examines key issues and questions that sponsors and contract partners must address.

Andrea Zobel, Senior Director Product Management, Clinical Trial Supply & Logistics, PAREXEL, discusses how clinical trial and logistics requirements for novel therapeutics differ from those for traditional therapies, and shares best practices for planning and collaboration.

Download BioPharm International's

2017 Outsourcing Resources eBook

Articles in this issue

Customer Relationship Management in Contract Manufacturing

Preparing an Approach to Cold Chain for Cell- and Tissue-Based Therapies

Getting Biopharmaceutical Tech Transfer Right the First Time

CMOs Tackle New Challenges

Gearing Up for Biosimilars

Insourcing vs Outsourcing: Choosing the Right Strategy

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!